Daily Ards Research Analysis
Analyzed 11 papers and selected 3 impactful papers.
Summary
Three studies advanced ARDS science across preclinical, supportive-care, and predictive domains. A mouse study identifies sigma-1 receptor signaling as essential for fluvoxamine’s protection against endotoxin-induced lung injury. An animal RCT shows very-high bicarbonate CRRT can control pH and enable ultra-low tidal volumes as effectively as adding ECCO2R, while a large MIMIC-IV machine-learning model (XGBoost) accurately predicts SCAP-associated ARDS using eight routinely available variables.
Research Themes
- Receptor-targeted therapies for inflammatory lung injury
- Renal-respiratory extracorporeal strategies enabling protective ventilation
- Data-driven early prediction of ARDS in severe pneumonia
Selected Articles
1. The sigma-1 receptor agonist fluvoxamine alleviates endotoxin-induced acute lung injury in mice.
In an LPS-induced lung injury model, fluvoxamine restored multiple respiratory mechanics parameters in wild-type mice but not in sigma-1 receptor knockouts, mirroring dexamethasone’s effects. The results pinpoint S1R signaling as necessary for fluvoxamine’s anti-inflammatory lung protection, nominating S1R as a druggable target in inflammatory lung injury.
Impact: This study provides receptor-specific mechanistic evidence linking sigma-1 receptor activation to protection from endotoxin lung injury, supporting drug repurposing of fluvoxamine and S1R-targeting strategies.
Clinical Implications: S1R agonism could offer an alternative or adjunct to glucocorticoids for inflammatory lung injury/early ARDS, warranting dose-finding and safety trials in humans.
Key Findings
- LPS reduced tidal volume, minute ventilation, and multiple flow parameters; fluvoxamine reversed these impairments in wild-type mice.
- Protective effects of fluvoxamine were absent in S1R knockout mice, indicating sigma-1 receptor dependence.
- Fluvoxamine’s effects paralleled dexamethasone, highlighting a receptor-specific anti-inflammatory mechanism.
Methodological Strengths
- Use of sigma-1 receptor knockout mice to establish receptor dependence
- Comprehensive assessment of respiratory mechanics with pharmacologic comparator (dexamethasone)
Limitations
- Preclinical LPS model may not fully recapitulate human ARDS heterogeneity
- Translational dosing and safety of S1R agonism in humans remain to be defined
Future Directions: Validate S1R-targeted therapy across diverse ARDS models and advance to dose-ranging, safety, and mechanistic biomarker studies in early-phase clinical trials.
INTRODUCTION: Acute lung inflammation has recently gained increasing attention due to the high acute respiratory distress syndrome complications with subsequent fibrosis during the COVID-19 pandemic. Our group identified that the antifibrotic effect of the antidepressant fluvoxamine (FLU) in various organs is meditated via sigma-1 receptor (S1R) agonism. Since the actions of FLU on the inflammatory components have not been elucidated, this study investigated its effects in a mouse model of interstitial pneumonitis. METHODS: Pneumonitis was induced in wild-type (WT) and S1R knockout ( RESULTS: LPS reduced tidal volume, minute ventilation, peak expiratory, inspiratory and mid-tidal expiratory flows. Similarly to the reference compound dexamethasone FLU counteracted all effects in WT, but not in CONCLUSION: Overall, FLU mitigates LPS-induced pulmonary inflammation and functional deterioration primarily via S1R signaling, highlighting a receptor-specific mechanism underlying its protective effects. Thus, targeting S1R may be an effective and safe alternative to other therapeutic approaches, including glucocorticoids to treat inflammatory lung injury.
2. High Bicarbonate Dialysis With or Without Extracorporeal Carbon Dioxide Removal for pH Control in a Swine Model of Acute Kidney Injury.
In a randomized swine AKI model with protocolized hypoventilation, very-high bicarbonate CRRT alone achieved pH control and ~50% tidal volume reduction equivalently to CRRT plus low-flow ECCO2R. Hemodynamics were comparable, suggesting high-bicarbonate CRRT can support ultra-low Vt strategies without ECCO2R.
Impact: The study challenges the assumption that ECCO2R is required to enable ultra-low tidal volume ventilation when severe acidemia limits protective strategies in ARDS with AKI.
Clinical Implications: In centers without ECCO2R, very-high bicarbonate CRRT may be a feasible alternative to manage acidemia and facilitate ultra-low Vt ventilation, meriting clinical testing and safety monitoring.
Key Findings
- Very-high bicarbonate CRRT alone corrected hypercapnic acidemia and enabled ~50% tidal volume reduction while maintaining pH ≥7.2.
- No significant differences versus CRRT plus low-flow ECCO2R in lowest achievable Vt or time to vasopressor initiation.
- Cardiac output was preserved despite rising vasopressor needs over the 12-hour protocol.
Methodological Strengths
- Randomized allocation between two clinically relevant extracorporeal strategies
- Clear physiological endpoints (pH maintenance, lowest Vt) over a standardized 12-hour protocol
Limitations
- Small sample size (n=12) and short observation window (12 hours)
- Model focused on AKI with hypoventilation rather than a full ARDS lung injury model; external validity to human ARDS uncertain
Future Directions: Conduct controlled clinical studies comparing high-bicarbonate CRRT versus CRRT+ECCO2R for acidemia control, including longer-term hemodynamics, electrolyte balance, and patient-centered outcomes.
In acute respiratory distress syndrome (ARDS) complicated by acute kidney injury (AKI), severe acidemia may limit implementation of protective ventilation. Continuous renal replacement therapy (CRRT) may improve acid-base control either by increasing dialysate bicarbonate concentration or by combining CRRT with extracorporeal carbon dioxide removal (ECCO 2 R). We compared these strategies in a randomized experimental model. Twelve anesthetized Landrace pigs underwent surgical induction of anuric AKI followed by protocolized hypoventilation with stepwise tidal volume (Vt) reduction. Animals were assigned to CRRT with very-high bicarbonate dialysate (60 mEq/L) alone or CRRT with high bicarbonate dialysate (40 mEq/L) plus low-flow ECCO 2 R. The primary outcomes were time to vasopressor initiation and the lowest Vt achieved while maintaining arterial pH ≥7.2 during a 12 hour protocol. Both strategies corrected hypercapnic acidemia and enabled substantial Vt reduction, approximately 50% from baseline, without differences between groups at 12 hours ( p = 0.756). Time to vasopressor initiation was likewise similar (hazard ratio [HR] = 0.76, 95% confidence interval [CI] = 0.21-2.71). Cardiac output remained preserved despite increasing vasopressor requirements. In this experimental AKI model, very-high bicarbonate CRRT provided short-term pH control comparable to CRRT plus ECCO 2 R, supporting ultralow-Vt ventilation.
3. ARDSML
Using MIMIC-IV data on 3,807 SCAP ICU patients, the authors selected eight key variables via LASSO and built multiple ML models. XGBoost achieved the best test AUROC (0.9466) and was deployed as a web calculator to predict SCAP-associated ARDS.
Impact: Provides an interpretable eight-variable, high-performing predictive model for SCAP-associated ARDS with internal validation and decision-curve analysis, facilitating early risk stratification.
Clinical Implications: If externally validated, this tool could enable earlier ARDS identification in severe pneumonia, trigger preventive bundles, and inform triage and monitoring intensity.
Key Findings
- From 80 candidates, eight variables (Charlson, lactate, stroke, race, anion gap, albumin, sepsis, ROX index) were selected via LASSO.
- XGBoost achieved the highest test performance (AUROC 0.9466), outperforming most other ML models.
- A web-based calculator was developed to operationalize risk prediction at the bedside.
Methodological Strengths
- Large ICU cohort with internal split-sample validation and multiple ML comparators
- Model evaluation included ROC, calibration, decision-curve analysis, and classification metrics
Limitations
- Retrospective single-database design; no external validation reported
- Potential residual confounding and missing data biases in EHR-derived variables
Future Directions: Pursue external, multicenter validation, prospective impact studies, and EHR integration with clinician-in-the-loop evaluation.
BACKGROUND: Early identification of acute respiratory distress syndrome (ARDS) in severe community-acquired pneumonia (SCAP) are crucial for reducing morbidity and mortality. This study focuses on developing an optimal prediction model based on clinical data and biomarkers to detect the risk of SCAP-associated ARDS in adult ICU patients. METHODS: This investigation, utilizing the MIMIC-IV database, enrolled 3,807 patients with SCAP and randomly allocated them into a training set (n=2,664) for model development and a testing set (n=1,143) as an internal validation cohort to assess the model's predictive performance. The outcome was defined as the incidence of SCAP-associated ARDS. Baseline clinical and laboratory characteristics of the patients were obtained. Selection of characteristic variables was performed using LASSO regression, followed by the construction of ten ML models: LGBM, KNN, CatBoost, SVM, XGBoost, DesicionTree, NB, RF, KNNC, and MLP. The evaluation of model performance is conducted through various indicators such as ROC curves, calibration curve, DCA, accuracy, specificity, recall, presicion and F1 score. RESULTS: Initially, 80 characteristic variables were collected, and then 67 of them were selected for the next analysis. After conducting a univariate regression analysis, 32 variables with P< 0.1 were gathered. Through a multicollinearity analysis(VIF≥10), 3 variables were deleted. The remaining 29 variables were subjected to LASSO regression analysis, and 8 of the most significant characteristic variables (Charlson, Lactate, Stroke, Race, AG, ALB, Sepsis, ROX) were selected to build 10 prediction models using machine learning methods. In the training set, the AUROC of the prediction models were respectively LGBM(AUROC=0.9770), KNN(AUROC=0.9879), CatBoost(AUROC=0.9827), SVM(AUROC=0.8095), XGBoost(AUROC=0.9999), DesicionTree(AUROC=0.7611), NB(AUROC=0.5759), RF(AUROC=0.8068), KNNC(AUROC=0.9879), and MLP(AUROC=0.9661). While in the test set, the AUROC were LGBM(AUROC=0.9355), KNN(AUROC=0.6343), CatBoost(AUROC=0.8745), SVM(AUROC=0.7912), XGBoost(AUROC=0.9466), DesicionTree(AUROC=0.7791), NB(AUROC=0.5765), RF(AUROC=0.8074), KNNC(AUROC=0.6343), and MLP(AUROC=0.7386). A web calculator utilizing 8 crucial variables to predict SCAP-associated ARDS in adult ICU patients for ARDSML CONCLUSION: The prediction model constructed based on 8 characteristic variables selected by LASSO regression and using the XGBoost algorithm has excellent predictive performance in predicting the occurrence of SCAP-associated ARDS in adult ICU patients. This data-driven predictive model will help clinicians to make quick and accurate diagnosis.